Core Laboratories Price To Sales vs. Cash And Equivalents

CLB Stock  USD 19.47  0.27  1.37%   
Based on Core Laboratories' profitability indicators, Core Laboratories NV is performing exceptionally good at this time. It has a great probability to showcase excellent profitability results in January. Profitability indicators assess Core Laboratories' ability to earn profits and add value for shareholders.

Core Laboratories Price To Sales Ratio

2.7

At present, Core Laboratories' Price To Sales Ratio is projected to slightly decrease based on the last few years of reporting. The current year's Days Sales Outstanding is expected to grow to 89.98, whereas Sales General And Administrative To Revenue is forecasted to decline to 0.05. At present, Core Laboratories' Net Income Per Share is projected to slightly decrease based on the last few years of reporting. The current year's Income Quality is expected to grow to 0.93, whereas Accumulated Other Comprehensive Income is forecasted to decline to (5.2 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.20.1845
Significantly Up
Slightly volatile
Operating Profit Margin0.140.1072
Significantly Up
Slightly volatile
For Core Laboratories profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Core Laboratories to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Core Laboratories NV utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Core Laboratories's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Core Laboratories NV over time as well as its relative position and ranking within its peers.
  

Core Laboratories' Revenue Breakdown by Earning Segment

Check out Trending Equities.
Is Oil & Gas Equipment & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.316
Dividend Share
0.04
Earnings Share
0.53
Revenue Per Share
11.158
Quarterly Revenue Growth
0.072
The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Core Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Core Laboratories Cash And Equivalents vs. Price To Sales Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Core Laboratories's current stock value. Our valuation model uses many indicators to compare Core Laboratories value to that of its competitors to determine the firm's financial worth.
Core Laboratories NV is rated below average in price to sales category among its peers. It is rated below average in cash and equivalents category among its peers creating about  8,475,526  of Cash And Equivalents per Price To Sales. At present, Core Laboratories' Price To Sales Ratio is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Core Laboratories' earnings, one of the primary drivers of an investment's value.

Core Cash And Equivalents vs. Price To Sales

Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

Core Laboratories

P/S

 = 

MV Per Share

Revenue Per Share

 = 
1.82 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

Core Laboratories

Cash

 = 

Bank Deposits

+

Liquidities

 = 
15.43 M
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).

Core Cash And Equivalents Comparison

Core Laboratories is currently under evaluation in cash and equivalents category among its peers.

Core Laboratories Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Core Laboratories, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Core Laboratories will eventually generate negative long term returns. The profitability progress is the general direction of Core Laboratories' change in net profit over the period of time. It can combine multiple indicators of Core Laboratories, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-5 M-5.2 M
Operating Income54.6 M51.9 M
Income Before Tax41.2 M39.1 M
Total Other Income Expense Net-13.4 M-12.8 M
Net Income37 M35.2 M
Income Tax Expense4.2 MM
Net Income Applicable To Common Shares22.4 M21.3 M
Net Income From Continuing Ops37 M35.2 M
Non Operating Income Net Other-1.2 M-1.2 M
Interest Income10.4 M9.8 M
Net Interest Income-13.4 M-14.1 M
Change To Netincome11.4 M9.8 M
Net Income Per Share 0.79  1.25 
Income Quality 0.67  0.93 
Net Income Per E B T 0.89  0.54 

Core Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Core Laboratories. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Core Laboratories position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Core Laboratories' important profitability drivers and their relationship over time.

Use Core Laboratories in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Core Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Core Laboratories will appreciate offsetting losses from the drop in the long position's value.

Core Laboratories Pair Trading

Core Laboratories NV Pair Trading Analysis

The ability to find closely correlated positions to Core Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Core Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Core Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Core Laboratories NV to buy it.
The correlation of Core Laboratories is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Core Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Core Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Core Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Core Laboratories position

In addition to having Core Laboratories in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Natural Foods Thematic Idea Now

Natural Foods
Natural Foods Theme
Companies producing natural foods including dairy products and different types of meets. The Natural Foods theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Natural Foods Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Core Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Core Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Core Laboratories Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Core Laboratories Nv Stock:
Check out Trending Equities.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
To fully project Core Laboratories' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Core Laboratories at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Core Laboratories' income statement, its balance sheet, and the statement of cash flows.
Potential Core Laboratories investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Core Laboratories investors may work on each financial statement separately, they are all related. The changes in Core Laboratories's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Core Laboratories's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.